These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28805295)

  • 1. Multiparametric magnetic resonance imaging identifies significant apical prostate cancers.
    Kenigsberg AP; Tamada T; Rosenkrantz AB; Llukani E; Deng FM; Melamed J; Zhou M; Lepor H
    BJU Int; 2018 Feb; 121(2):239-243. PubMed ID: 28805295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.
    Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M
    BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer detection using multiparametric 3 - tesla MRI and fusion biopsy: preliminary results.
    Mussi TC; Garcia RG; Queiroz MR; Lemos GC; Baroni RH
    Int Braz J Urol; 2016; 42(5):897-905. PubMed ID: 27532112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
    Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
    BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Multiparametric Prostate Magnetic Resonance Imaging Structured Report Informs Risk for Positive Apical Surgical Margins During Radical Prostatectomy.
    Costa DN; Meng X; Tverye A; Bagrodia A; Recchimuzzi DZ; Xi Y; Arraj P; Shah RB; Subramanian N; de Leon AD; Roehrborn CG; Rofsky NM; Chen H; Pedrosa I
    J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):38-44. PubMed ID: 35995580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction.
    Distler FA; Radtke JP; Bonekamp D; Kesch C; Schlemmer HP; Wieczorek K; Kirchner M; Pahernik S; Hohenfellner M; Hadaschik BA
    J Urol; 2017 Sep; 198(3):575-582. PubMed ID: 28373135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
    von Below C; Wassberg C; Norberg M; Tolf A; Kullberg J; Ladjevardi S; Häggman M; Bill Axelson A; Ahlström H
    Scand J Urol; 2017 Apr; 51(2):107-113. PubMed ID: 28635568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
    Acta Radiol; 2018 Mar; 59(3):371-380. PubMed ID: 28679325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Transperineal Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Compared to Transrectal Systematic Biopsy in the Prediction of Tumour Aggressiveness in Patients with Previously Negative Biopsy.
    Borkowetz A; Renner T; Platzek I; Toma M; Herout R; Baunacke M; Groeben C; Huber J; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth MP
    Urol Int; 2019; 102(1):20-26. PubMed ID: 30149386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer.
    Porpiglia F; Russo F; Manfredi M; Mele F; Fiori C; Regge D
    Int Braz J Urol; 2015; 41(1):124-33. PubMed ID: 25928518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level.
    Beksac AT; Cumarasamy S; Falagario U; Xu P; Takhar M; Alshalalfa M; Gupta A; Prasad S; Martini A; Thulasidass H; Rai R; Berger M; Hectors S; Jordan J; Davicioni E; Nair S; Haines K; Lewis S; Rastinehad A; Yadav K; Jayaratna I; Taouli B; Tewari A
    J Urol; 2018 Dec; 200(6):1241-1249. PubMed ID: 30563651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of multiparametric magnetic resonance imaging to detect significant prostate cancer and index lesion location.
    Goldman H; Singh N; Harding C; McGirr J; Seal A; Duncan I; Sowter S
    ANZ J Surg; 2019 Jan; 89(1-2):106-110. PubMed ID: 30257273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric magnetic resonance imaging predicts the presence of prostate cancer in patients with negative prostate biopsy.
    Lista F; Castillo E; Gimbernat H; Rodríguez-Barbero JM; Panizo J; Angulo JC
    Actas Urol Esp; 2015 Mar; 39(2):85-91. PubMed ID: 25267460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer.
    Feng TS; Sharif-Afshar AR; Smith SC; Miller J; Nguyen C; Li Q; Luthringer D; Li D; Saouaf R; Kim HL
    Urol Oncol; 2015 Mar; 33(3):109.e15-22. PubMed ID: 25512160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.